Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Invested Capital (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Invested Capital for 12 consecutive years, with $64.4 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 428.22% to $64.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.4 million through Dec 2025, up 428.22% year-over-year, with the annual reading at $64.4 million for FY2025, 428.22% up from the prior year.
  • Invested Capital hit $64.4 million in Q4 2025 for vTv Therapeutics, down from $70.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $70.5 million in Q3 2025 to a low of -$56.3 million in Q1 2021.
  • Historically, Invested Capital has averaged -$2.5 million across 5 years, with a median of -$9.1 million in 2021.
  • Biggest five-year swings in Invested Capital: tumbled 196.54% in 2023 and later soared 428.22% in 2025.
  • Year by year, Invested Capital stood at -$9.7 million in 2021, then decreased by 10.27% to -$10.7 million in 2022, then crashed by 129.8% to -$24.7 million in 2023, then soared by 149.43% to $12.2 million in 2024, then skyrocketed by 428.22% to $64.4 million in 2025.
  • Business Quant data shows Invested Capital for VTVT at $64.4 million in Q4 2025, $70.5 million in Q3 2025, and $2.4 million in Q2 2025.